Clicky

Adherium Ltd  (ADR)

Description: Adherium Limited is principally engaged in the development, manufacture and supply of its Smartinhaler digital health technologies, which address sub-optimal medication use and improve health outcomes in chronic disease. It offers a range of smart devices for respiratory medications globally. Its Smartinhaler platform supports asthma and chronic obstructive pulmonary disease (COPD) medication adherence solution. The Bluetooth enabled Smartinhaler medication sensors wrap around patients existing inhalers and automatically send usage data to their smartphone. The Smartinhaler application enables patients and healthcare professionals to track medication adherence, set daily reminders, and discover insights into their medication usage. Its application also enables real-time reporting, monitoring, storing and analysis of inhaler use. The SmartinhalerLive platform uses wireless communications technology to provide real time data collection and reporting from the its Smartinhalers.


Keywords: Medicine Disease Communication Medication Communications Wireless Bluetooth Asthma Chronic Disease Respiratory Therapy Smart Device Chronic Obstructive Pulmonary Disease Data Collection Communications Technology Copd Inhaler Optima Insights Metered Dose Inhaler Chronic Lower Respiratory Diseases Dry Powder Inhaler Health Technologies Wireless Communications Technology

Home Page: www.adherium.com

ADR Technical Analysis

63 Albert Street
Auckland, 1010
New Zealand
Phone: 64 9 307 2771


Officers

Name Title
Mr. Rick Legleiter B.S., M.B.A. Chief Exec. Officer
Mr. Geoff Feakes Chief Technology Officer
Mr. Rob Turnbull B.Com., C.A., B.Com, CA. GM & Joint Company Sec.
Mr. Mark Andrew Licciardo B Bus (Acc), FCIS, FGIA, GAICD, GradDip CSP Joint Company Sec.
Mr. Daniel Kaplon Chief Financial Officer
Ms. Kirsty Rutledge-Malyon HR Mang.
Ms. Maggie Scott Head of Clinical Operations
Mr. Michael Motion Consultant
Dr. John Douglas Wilson Exec. Medical Director

Exchange: AU

Country: AU

Currency: Australian Dollar (A$)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 4.3822
Price-to-Sales TTM: 37.6517
IPO Date:
Fiscal Year End: June
Full Time Employees: 0
Back to stocks